Praxis Precision Medicines, Inc.
PRAX
$305.00
$11.053.76%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 7.46M | 7.77M | 8.12M | 8.55M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 7.46M | 7.77M | 8.12M | 8.55M |
| Cost of Revenue | 267.12M | 245.90M | 221.98M | 186.24M | 152.41M |
| Gross Profit | -267.12M | -238.43M | -214.22M | -178.11M | -143.86M |
| SG&A Expenses | 59.08M | 54.68M | 57.37M | 54.89M | 56.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 326.20M | 300.57M | 279.35M | 241.13M | 208.72M |
| Operating Income | -326.20M | -293.11M | -271.59M | -233.01M | -200.17M |
| Income Before Tax | -303.27M | -273.04M | -251.01M | -212.56M | -182.82M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -303.27 | -273.04 | -251.01 | -212.56 | -182.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -303.27M | -273.04M | -251.01M | -212.56M | -182.82M |
| EBIT | -326.20M | -293.11M | -271.59M | -233.01M | -200.17M |
| EBITDA | -326.06M | -292.95M | -271.35M | -232.71M | -199.81M |
| EPS Basic | -13.47 | -12.90 | -12.29 | -10.71 | -10.27 |
| Normalized Basic EPS | -8.54 | -8.26 | -7.87 | -6.89 | -6.58 |
| EPS Diluted | -13.47 | -12.90 | -12.29 | -10.71 | -10.27 |
| Normalized Diluted EPS | -8.54 | -8.26 | -7.87 | -6.89 | -6.58 |
| Average Basic Shares Outstanding | 89.92M | 84.49M | 81.40M | 78.75M | 71.59M |
| Average Diluted Shares Outstanding | 89.92M | 84.49M | 81.40M | 78.75M | 71.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |